OptimizeRx
OPRX62
$4.87arrow_drop_up8.90%$0.39
Penny Stock
OPRX62
$4.87
arrow_drop_up8.90%Performance History
| Key Stats | |
|---|---|
| Open | $4.53 |
| Prev. Close | $4.49 |
| EPS | -1.34 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $89.70M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 4.46 | 4.97 |
| 52 Week Range | 3.80 | 16.65 |
| Ratios | |
|---|---|
| EPS | -1.34 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About OptimizeRx (OPRX)
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. William J. Febbo
- Headquarters
- Rochester
- Employees
- 109
- Exchange
- NASDAQ
Keep an eye on OptimizeRx
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is OptimizeRx's (OPRX) price per share?
The current price per share for OptimizeRx (OPRX) is $4.87. The stock has seen a price change of $0.4 recently, indicating a 8.91% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for OptimizeRx (OPRX)?
For OptimizeRx (OPRX), the 52-week high is $16.65, which is 241.89% from the current price. The 52-week low is $3.8, the current price is 28.16% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is OptimizeRx (OPRX) a growth stock?
OptimizeRx (OPRX) has shown an average price growth of -3.66% over the past three years. It has received a score of 2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying OptimizeRx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is OptimizeRx (OPRX) stock price performance year to date (YTD)?
As of the latest data, OptimizeRx (OPRX) has a year-to-date price change of -65.31%. Over the past month, the stock has experienced a price change of -15.16%. Over the last three months, the change has been -43.37%. Over the past six months, the figure is -60.41%. Looking at a longer horizon, the five-year price change stands at -54.84%.
help
Is OptimizeRx (OPRX) a profitable company?
OptimizeRx (OPRX) has a net income of -$17.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 59.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -5.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $71.52M, with a revenue growth rate of 14.53%, providing insight into the company's sales performance and growth. The gross profit is $42.9M. Operating income is noted at -$26.4M. Furthermore, the EBITDA is -$3.33M.
help
What is the market capitalization of OptimizeRx (OPRX)?
OptimizeRx (OPRX) has a market capitalization of $89.71M. The average daily trading volume is 4.75, indicating the stock's liquidity and investor engagement.
News
EARNINGS
EARNINGS ESTIMATES
EARNINGS OUTLOOK
INDUSTRY OUTLOOK
ZACKS RANK
Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates
MARKET RESEARCH REPORTS
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
ANALYST RATINGS
Expert Ratings For OptimizeRx
EARNINGS RELEASES AND OPERATING RESULTS
OptimizeRx Reports First Quarter 2024 Financial Results
May 13, 2024
Does OptimizeRx (OPRX) Have the Potential to Rally 34.78% as Wall Street Analysts Expect?
CALENDAR OF EVENTS
OptimizeRx to Participate in Upcoming Investor Conferences